Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis

NCT01955980 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinosinusitis

Interventions

DRUG: Budesonide
DRUG: Budesonide

Sponsor

Pari Pharma GmbH